Foghorn Therapeutics logo

Foghorn Therapeutics share price today

(FHTX)

Foghorn Therapeutics share price is $4.59 & ₹393.55 as on 3 Jan 2025, 2.30 'hrs' IST

$4.59

-0.13

(-2.75%)

Market is closed - opens 8 PM, 03 Jan 2025

View live Foghorn Therapeutics share price in Dollar and Rupees. Guide to invest in Foghorn Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Foghorn Therapeutics. Get details on the Indian mutual funds that are investing in Foghorn Therapeutics. Get Analyst recommendations and forecasts along with all the Foghorn Therapeutics's financials.

Foghorn Therapeutics share price movements

  • Today's Low: $4.54
    Today's High: $4.94

    Day's Volatility :8.1%

  • 52 Weeks Low: $2.70
    52 Weeks High: $10.25

    52 Weeks Volatility :73.66%

Foghorn Therapeutics Returns

PeriodFoghorn Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-39.72%
-10.0%
0.0%
6 Months
-10.94%
-4.7%
0.0%
1 Year
-15.71%
-0.9%
0.0%
3 Years
-78.64%
-2.4%
-21.2%

Foghorn Therapeutics Key Statistics

in dollars & INR

Previous Close
$4.72
Open
$4.81
Today's High
$4.94
Today's Low
$4.54
Market Capitalization
$262.4M
Today's Volume
$144.5K
52 Week High
$10.25
52 Week Low
$2.7
Revenue TTM
$25.5M
EBITDA
$-98.5M
Earnings Per Share (EPS)
$-1.85
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-470.38%

How to invest in Foghorn Therapeutics from India?

It is very easy for Indian residents to invest directly in Foghorn Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Foghorn Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Foghorn Therapeutics or FHTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Foghorn Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Foghorn Therapeutics shares which would translate to 0.187 fractional shares of Foghorn Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Foghorn Therapeutics, in just a few clicks!

Returns in Foghorn Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Foghorn Therapeutics investment value today

Current value as on today

₹84,939

Returns

₹15,061

(-15.06%)

Returns from Foghorn Therapeutics Stock

₹18,036 (-18.04%)

Dollar Returns

₹2,975 (+2.97%)

Indian investors sentiment towards Foghorn Therapeutics

400%

Period: Oct 4, 2024 to Jan 2, 2025. Change in 30 Days versus previous period

Search volume for Foghorn Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 3, 2025. 400% more investors are searching Foghorn Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Foghorn Therapeutics

  • Flagship Ventures Management, Inc.

    22.80%

  • FMR Inc

    11.39%

  • Bvf Inc

    9.54%

  • Deerfield Management Co

    5.45%

  • Raymond James & Associates

    4.13%

  • Vanguard Group Inc

    3.12%

Analyst Recommendation on Foghorn Therapeutics

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Foghorn Therapeutics(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Foghorn Therapeutics

What analysts predicted

Upside of 161.44%

Current:

$4.59

Target:

$12.00

Insights on Foghorn Therapeutics

  • Price Movement

    In the last 7 days, FHTX stock has moved down by -7.3%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 5.05M → 7.80M (in $), with an average increase of 19.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -25.01M → -19.12M (in $), with an average increase of 14.5% per quarter
  • FHTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 20.7% return, outperforming this stock by 47.5%
  • FHTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 118.2%
  • Price to Sales

    ForFHTX every $1 of sales, investors are willing to pay $9.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Foghorn Therapeutics Technicals Summary

Sell

Neutral

Buy

Foghorn Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Foghorn Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Foghorn Therapeutics Inc
-38.06%
-10.94%
-15.71%
-78.64%
-73.95%
Regeneron Pharmaceuticals, Inc.
-4.97%
-31.12%
-21.91%
15.48%
91.62%
Biontech Se
-1.42%
42.28%
6.01%
-49.15%
155.61%
Alnylam Pharmaceuticals, Inc.
-6.56%
-6.26%
22.36%
42.41%
102.91%
Vertex Pharmaceuticals Incorporated
-11.88%
-15.14%
-3.23%
81.51%
79.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Foghorn Therapeutics Inc
NA
NA
NA
-1.56
-4.7
-0.2
NA
-0.51
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Foghorn Therapeutics Inc
Buy
$262.4M
-73.95%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
91.62%
17.61
33.61%
Biontech Se
Buy
$27.3B
155.61%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
102.91%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
79.75%
32.84
-4.51%

About Foghorn Therapeutics

foghorn therapeutics inc., a biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. the company uses its proprietary gene traffic control platform to identify, validate, and potentially drug targets within the system. it is developing fhd-286, a small-molecule enzymatic inhibitor of brg1 and brm for the treatment of acute myeloid leukemia and uveal melanoma; and fhd-609, a small molecule protein degrader of brd9 to treat patients with synovial sarcoma. the company is also developing preclinical and discovery programs, including selective brm targeting non-small-cell lung cancer; and selective arid1b modulators for bladder, ovarian, and endometrial cancer. it has a collaboration with merck sharp & dohme corp. to discover and develop novel oncology therapeutics against a transcription factor target. the company was founded in 2015 and is headquartered in cambridge, massachusetts.
Organization
Foghorn Therapeutics
Employees
116
CEO
Mr. Adrian H. B. Gottschalk
Industry
Health Technology

Management People of Foghorn Therapeutics

NameTitle
Mr. Adrian H. B. Gottschalk
President, CEO & Director
Dr. Steven F. Bellon Ph.D.
Chief Scientific Officer
Dr. Alfonso Quintas Cardama M.D.
Chief Medical Officer
Dr. Gerald R. Crabtree M.d.
Founder & Member of Scientific Advisory Board
Mr. Kristian Humer M.B.A.
Chief Financial Officer
Ms. Karin Hellsvik
Chief of Staff to the CEO, VP of Corporate Affairs & Investor Relations
Mr. Michael J. LaCascia J.D.
Chief Legal Officer
Mr. Saurabh Sewak Ph.D.
Vice President of Corporate Development
Mr. Carlos Costa
Chief People Officer
Dr. Anna Rivkin Ph.D.
Chief Business Officer

Important FAQs about investing in Foghorn Therapeutics from India :

What is Foghorn Therapeutics share price today?

Foghorn Therapeutics share price today stands at $4.59, Open: $4.81 ; Previous Close: $4.72 ; High: $4.94 ; Low: $4.54 ; 52 Week High: $10.25 ; 52 Week Low: $2.70. The stock opens at $4.81, after a previous close of $4.72. The stock reached a daily high of $4.94 and a low of $4.54, with a 52-week high of $10.25 and a 52-week low of $2.70.

Can Indians buy Foghorn Therapeutics shares?

Yes, Indians can invest in the Foghorn Therapeutics (FHTX) from India.

With INDmoney, you can buy Foghorn Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Foghorn Therapeutics at zero transaction cost.

How can I buy Foghorn Therapeutics shares from India?

It is very easy to buy Foghorn Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Foghorn Therapeutics be purchased?

Yes, you can buy fractional shares of Foghorn Therapeutics with INDmoney app.

What are the documents required to start investing in Foghorn Therapeutics stocks?

To start investing in Foghorn Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Foghorn Therapeutics

Today’s highest price of Foghorn Therapeutics (FHTX) is $4.94.

Today’s lowest price of Foghorn Therapeutics (FHTX) is $4.54.

What is today's market capitalisation of Foghorn Therapeutics

Today's market capitalisation of Foghorn Therapeutics FHTX is 262.4M

What is the 52 Week High and Low Range of Foghorn Therapeutics

  • 52 Week High

    $10.25

  • 52 Week Low

    $2.70

What are the historical returns of Foghorn Therapeutics?

  • 1 Month Returns

    -38.06%

  • 3 Months Returns

    -10.94%

  • 1 Year Returns

    -15.71%

  • 5 Years Returns

    -73.95%

Who is the Chief Executive Officer (CEO) of Foghorn Therapeutics

Mr. Adrian H. B. Gottschalk is the current Chief Executive Officer (CEO) of Foghorn Therapeutics.